Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics by Kavanagh, Matthew M. et al.
Georgetown University Law Center 
Scholarship @ GEORGETOWN LAW 
2020 
Access to lifesaving medical resources for African countries: 
COVID-19 testing and response, ethics, and politics 
Matthew M. Kavanagh 
Department of International Health, Georgetown University, mk1915@law.georgetown.edu 
Ngozi A. Erondu 
Centre for Universal Health, Chatham House, London, U.K. 
Oyewale Tomori 
Redeemer's University, Ede, Nigeria 
Victor J. Dzau 
National Academy of Medicine 
Emelda A. Okiro 
KEMRI-Wellcome Trust Research Programme, Narobi, Kenya 
See next page for additional authors 
 
 




The Lancet, Vol. 395, Issue 10238, Pp. 1735-1738. 
This open-access article is brought to you by the Georgetown Law Library. Posted with permission of the author. 
Follow this and additional works at: https://scholarship.law.georgetown.edu/facpub 
 Part of the Health Law and Policy Commons, and the International Humanitarian Law Commons 
Authors 
Matthew M. Kavanagh, Ngozi A. Erondu, Oyewale Tomori, Victor J. Dzau, Emelda A. Okiro, Allan Maleche, 
Ifeyinwa C. Aniebo, Umunya Rugege, Charles B. Holmes, and Lawrence O. Gostin 
This article is available at Scholarship @ GEORGETOWN LAW: https://scholarship.law.georgetown.edu/facpub/2279 
Viewpoint
www.thelancet.com   Published online May 7, 2020   https://doi.org/10.1016/PII 1
Access to lifesaving medical resources for African countries: 
COVID-19 testing and response, ethics, and politics
Matthew M Kavanagh, Ngozi A Erondu, Oyewale Tomori, Victor J Dzau, Emelda A Okiro, Allan Maleche, Ifeyinwa C Aniebo, Umunya Rugege, 
Charles B Holmes, Lawrence O Gostin
Introduction
Coronavirus disease 2019 (COVID-19) has revealed how 
strikingly unprepared the world is for a pandemic and 
how easily viruses spread in our interconnected world. 
A governance crisis is unfolding alongside the pandemic 
as health officials around the world compete for access to 
scarce medical supplies. As governments of African 
countries, and those in low-income and middle-income 
countries around the world, seek to avoid potentially 
catastrophic epidemics and learn from what has worked 
in other countries, testing and other medical resources 
are of concern. With accelerating spread, funding is 
urgently needed. Yet even where there is enough money, 
many African health authorities are unable to obtain the 
supplies needed as geopolitically powerful countries 
mobilise economic, political, and strategic power to 
procure stocks for their populations.1,2
We have seen this before. In the AIDS pandemic 
lifesaving diagnostics and drugs came to many African 
countries long after they were available in Europe and 
North America. In 2020, this situation can be avoided. 
Although health system weakness remain acute in 
many places, investments by national governments, the 
African Union, and international initiatives to tackle 
AIDS, tuberculosis, malaria, polio, and post-Ebola 
global health security have built important public health 
capacities. Global leaders have an ethical obligation to 
avoid needless loss of life due to the foreseeable prospect 
of slow and inadequate access to supplies in Africa.
COVID-19 testing and response strategies
Having navigated Ebola, HIV, and tuberculosis epi demics, 
and a range of annual, sporadic, and concurrent outbreaks, 
several African countries have unparalleled disease 
response capacity. African govern ments are offering rare 
examples of effective international cooperation on 
COVID-19. The African Union started early to strengthen 
response with readiness assessments, an emergency 
ministerial meeting, and a continental strategy. However, 
with a highly transmissible and fast spreading virus these 
strengths can quickly be overwhelmed.
In the absence of a vaccine or highly-effective 
treatment, widespread testing is crucial to halting 
transmission and death, especially with presymptomatic 
transmission responsible for up to 44% of secondary 
infections.3 For example, South Africa, South Korea, and 
Germany are reporting tentative signs of success through 
mass testing, isolation, contact tracing, and physical 
distancing. Extensive testing efforts have been key to 
some of the lowest fatality rates in the world.4 South 
Africa, which has the second largest economy in Africa, 
put community testing at the core of its multifaceted 
response. Although testing 2·7 per thousand members 
of the population is lower than Germany and South Korea, 
the strategy in South Africa—with over 4000 reported 
cases and 79 deaths as of April 25, 2020—is yielding 
similar fatality rates.5 With only 2·8% of those tested 
being positive for COVID-19, there is hope for rapidly 
scaling testing to detect and halt community spread.5
COVID-19 cases have been reported across the African 
continent—with the number of confirmed cases passing 
30 000 on April 25, 2020.5 These numbers reflect 
restricted testing as higher capacity countries, such as 
South Africa, Morocco, and Algeria, report many times 
more cases than countries with lower testing capacity 
(eg, Nigeria). The African CDC has announced a plan for 
1 million tests and a promising partnership aiming to 
produce 10 million tests, but this will not solve the 
immediate need.6
National contexts and responses are diverse—which 
will continue in the short-term and longer-term. African 
governments are applying an assortment of non-
pharmaceutical interventions including quarantines, 
curfews, closures of markets and schools, and restrictions 
on the types and number of attendees at social gatherings, 
with successes and challenges. Rwanda, a country of 
12 million people with a universal health care structure, 
implemented a lockdown shortly after the first detected 
case of COVID-19 (reported on March 8, 2020) and the 
government is supplying 20 000 households with free 
food through a social protection scheme. Ethiopia, one of 
Africa’s largest countries of over 100 million people, 
declared a state of emergency, postponed highly antici-
pated elections, and closed borders, but has not 
implemented a lockdown movement in the country.
In many high population density, unplanned areas of 
Africa’s megacities, distancing is not feasible. Where 
informal employment is common, the social and 
economic consequences of shutdowns will be severe. 
Many people face food insecurity and economic crises 
amidst lockdowns. Targeted interventions, informed by 
testing, are needed to allow day-wage workers to work 
and children who are at a higher-risk of the disease to 
return to school.
Testing strategies are key to ameliorating economic 
and social hardship, concentrating resources, and 
allowing more targeted interventions. For example, 
South Korea has been able to avoid the kind of full-scale 
lockdowns required elsewhere. In South Africa, testing 
data has informed a five-tier risk adjusted strategy to 
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ease lockdown measures based on incidence and 
readiness.
Meanwhile, China’s 3·6 critical care beds per 
100 000 population was insufficient during the COVID-19 
epidemic.7 Malawi has as few as 25 critical care beds for 
19 million people—or 0·1 beds per 100 000 people,8 and 
most counties in Kenya reportedly have no functioning 
ventilators.9 Although a lower median age might help, 
the number of people with malnutrition, HIV, and 
tuberculosis in the region could increase the need for 
critical care. In Veneto, Italy home-based care was 
combined with widespread testing and early diagnosis, 
resulting in a mortality rate four-times lower than that 
reported in Lombardy.10 Such home-based care could be a 
model for African contexts, building on community-level 
response experiences from the West African Ebola 
outbreak.11
Africa competes for testing kits and a future 
vaccine
Rolling out testing, tracing, and care across Africa will not 
be easy. Increased funding from national governments 
and donors is urgently needed. But recent investments 
have created important capacities. Africa CDC is providing 
strong coordination and COVID-19 guidance; additionally, 
strengthened national public health institutes, referral 
laboratories, laboratory and epidemiology workforce, 
infection control, and community networks are ready to 
be harnessed. By March 7, 2020, laboratories in 43 African 
countries could already do COVID-19 testing.12 Africa 
leads much of the world in community health-care 
networks that could be mobilised for the hard work of 
communication, testing, and contact tracing.13
However, restricted supplies of test reagents and 
consumables is making it difficult to mobilise capacity. 
The manufacturers of PCR platforms, such as Roche, 
Abbott, Hologic, Thermo Fisher, and Cepheid) cannot 
scale up production quickly enough. A WHO-validated 
rapid diagnostic test could provide a faster and  cheaper 
alternative to PCR.14 Currently, only a few rapid immuno-
diagnostic tests with high specificity and sensitivity are 
available and only in higher-income settings.
Countries in Africa have worked to procure swabs, 
reagents, test cartridges, and other commodities using 
national and donor funds. This is a complex endeavor 
with bottlenecks in procuring multiple laboratory 
consumables, specific to the platforms in a given 
geography. Despite best efforts, procurement remains a 
problem. One of the biggest deliveries has been tens of 
thousands of tests to each African Union member state 
from the Jack Ma Foundation, but additional components 
need to be procured.15 Africa CDC has a plan to distribute 
1 million tests,6 but even with a newly established pooled 
purchasing platform that secured 100 000 tests from 
Germany, in April, 2020, the continent falls very short 
from the tens of millions tests the UN estimates will be 
required.16 Health officials report procurements have 
been unsuccessful because supplies have already been 
purchased for use in North America and Europe.17,18 
There are several factors slowing testing—from demand 
to insufficient staff and specimen referral systems. 
However, the need for diagnostics has never been higher.
Many countries with successful testing strategies 
have rapidly reached at least 1% of their population. By 
early April, South Korea had tested 1% of its entire 
population while Germany surpassed 1·5%, now testing 
over 500 000 people each week.19 The table shows the 
numbers of tests needed to reach this level in African 
countries for which data is complete, compared with the 
low reported numbers of COVID tests done. Yet, with the 
expansion of funding and supplies, widespread testing is 
possible (eg, using trained staff and platforms from the 
AIDS and tuberculosis response). The table also shows 
over half of countries did more HIV tests between 
Oct 1, 2019 and Dec 31, 2019 than the 1% target for 
COVID-19 testing; capacity for more complex HIV viral 
load testing last year approached this level.
On vaccines and therapies, the current situation of 
inequitable access will repeat without action, as leaders 
highlighted at the launch of a new international effort to 
accelerate COVID-19 tools.20 Rich countries monopolising 
vaccine markets would mirror past actions.21 Meanwhile, 
demand for masks, gloves, and other personal protective 
















South Africa 593 087 161 004 7 287 515 2 730 530
Kenya 537 713 16 738 2 177 170 1 046 910
Uganda 457 410 20 329 2 098 734 1 012 685
Mozambique 312 554 1 644 1 814 959 583 689
Tanzania 597 342 652 1 462 879 913 255
Nigeria 2 061 396 10 061 1 160 920 576 469
Malawi 191 300 617 1 060 031 539 532
Zambia 183 840 5 341 948 247 643 163
Zimbabwe 148 629 6 067 645 402 487 182
Côte d’Ivoire 263 783 1 545 495 543 200 337
DR Congo 895 614 1 425 203 859 72 549
Cameroon 265 459 6 352 197 965 89 113
Rwanda 129 522 18 556 187 915 85 657
Ethiopia 1 149 636 13 645 136 307 332 528
South Sudan 111 937 91 79 992 13 284
Burundi 118 908 204 61 074 33 772
Botswana 23 516 4 432 36 219 145 776
Ghana 310 729 68 591 25 426 13 733
Overall 8 352 375 337 294 20 080 157 9 520 164
Only countries for which there is full data available are included. Data obtained 
from Africa CDC  and PEPFAR Panorama.COVID-19=coronavirus disease 2019. 
*Test done up until April 26, 2020.
Table: COVID-19 testing needs and HIV testing in selected countries in 
sub-Saharan Africa
For more on Africa CDC see 
https://africacdc.org/covid-19/
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Ethics and human rights in pandemics
The ethical frameworks for allocating scarce resources 
largely apply within, not between, countries.22 WHO 
instruments like the International Health Regulations 
and Pandemic Influenza Framework are inapplicable. 
Binding human rights treaties are not specific on 
distributing scarce goods in health emergencies.23 World 
Trade Organization rules require free flow of medical 
goods in the market, with little provision for crises when 
markets inequitably distribute goods in ways that 
undermine public health.
The AIDS pandemic should have taught us this lesson. 
Scale up of HIV diagnosis and treatment in African 
public health systems arrived years after North America 
and Europe, long after the pandemic had taken hold.24 In 
HIV, market forces impeded access through insufficient 
financing, high prices, and intellectual property barriers. 
In COVID-19, market forces are different—adding 
unequal procurement power. Yet the results will be the 
same without action.
Governments have an obligation to protect their own 
citizens. However, principles of fairness must be applied. 
No single community, country, or continent should bear 
the full brunt of global shortages. Although difficult 
decisions in resource allocation are inevitable, it is 
unethical for African countries to have considerably less 
access and harder choices than others.
Toward coordinated effort for ethical access
Political leadership is urgently required to secure ethical 
global allocation of scarce resources. It is entirely 
foreseeable that many countries will be locked out of the 
market. Governments have structured the global trading 
system and they have the power now to ameliorate its ill 
effects during a crisis. This is an ethical imperative but 
also a shared interest; the COVID-19 pandemic has 
taught us that unaddressed outbreaks in one part of the 
world put people throughout the world at risk.
Political convening is urgent, yet many international 
forums are struggling without consensus from powerful 
states. It will be hard to convince some governments to 
do anything besides maximising access for their own 
citizens. A new COVID-19 accelerator on vaccines, 
diagnostics, and treatments could offer a promising 
venue in a moment where international cooperation is at 
a low point. With leadership from the extended G20 and 
EU, coordinated by WHO, it engages a range of financing 
agencies including the Gates Foundation, World Bank, 
Global Fund, Global Alliance for Vaccines and 
Immunization, and Wellcome Trust. To be effective, the 
effort must be transparent, bold, collaborative, and 
explicitly address thorny ethnical issues in affordability, 
access, and distribution for the global public good. It 
needs to include strong African leadership and must be 
conscious of the “asymmetrical power structures that 
still dominate the largely high-income-country concept 
of global health.”25 Governments in advanced economies 
must not ignore the effects of market forces and their 
procurements on other countries.
Short-term and medium-term actions are needed. The 
African Union’s Partnership to Accelerate COVID-19 
Testing (PACT) is an important step. WHO has been 
providing critical support through guidelines, convening, 
and coordinated programmes. Pooling regional procur-
ement is needed, which can be improved through 
cooperation between Africa CDC and the WHO-led UN 
Supply Chain Taskforce, the Global Fund to Fight AIDS, 
Tuberculosis, and Malaria, and other organisations. 
Mechanisms for equitable distribution might require 
decisions based on population size and risk, prioritising 
health workers, and allowing countries to draw down 
allocations of supplies as needed without fear of losing 
access. African governments must mobilize domestic 
funds, while bilateral and multilateral aid must be 
increased—with resources flowing in weeks, not months. 
External funding streams could be channeled through 
existing mechanisms like the Global Fund, which opened 
a new mechanism to receive and distribute funds for 
COVID-19 in April 9, 2020. Securing open access to 
newly developed products and fair pricing will require 
coordinated action by WHO and national governments.
Serious efforts to overcome barriers to regional 
production and reduce reliance on foreign equipment are 
overdue—for diagnostics, personal protective equipment, 
and with sufficient investment for both vaccines and 
therapies. South Africa, Kenya, Zimbabwe, and Morocco 
have begun either scaling up existing production or 
converting universities and non-health industries to 
improve access to personal protective equipment. A 
partnership, led by Institut Pasteur, Dakar, Senegal, is 
advancing a prototype affordable, rapid test that could be 
produced in the millions.26 Past lessons show that national 
governments can incentivise production, but international 
cooperation has been shown to be criucial for ensuring 
financing and technology transfer—with collaboration 
between governments and manufacturers in low-income 
and middle-income countries particularly powerful.27
Conclusion
Every life has equal worth. Yet global allocation of testing 
and other goods currently means that some are forced to 
wait, while those ahead in the global procurement line take 
precedence. In 2020, we have the opportunity to learn 
from past mistakes by countering market forces, thus 
ensuring that lives on the African continent count equally. 
Doing so will take both moral clarity and political courage.
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